Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
159.50
-6.84 (-4.11%)
At close: Mar 11, 2026, 4:00 PM EDT
159.51
+0.01 (0.01%)
After-hours: Mar 11, 2026, 7:35 PM EDT

Axsome Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
8,1599,2934,1183,7693,3551,429
Market Cap Growth
27.99%125.69%9.26%12.33%134.83%-53.08%
Enterprise Value
8,0549,1853,9923,5683,2481,391
Last Close Price
159.50182.6484.6179.5977.1337.78
PE Ratio
--49.63-14.13-15.10-16.77-10.89
PS Ratio
12.7814.5510.6813.9367.05-
PB Ratio
91.92105.2572.2219.7330.6291.41
P/TBV Ratio
89.87102.9071.1118.9328.6290.93
P/FCF Ratio
--98.99-32.00-25.87-28.62-13.16
P/OCF Ratio
--99.49-32.07-25.98-28.80-13.20
EV/Sales Ratio
12.6114.3910.3513.1864.92-
EV/EBITDA Ratio
--58.25-14.64-15.86-18.52-11.16
EV/EBIT Ratio
--55.08-14.23-15.39-18.07-11.16
EV/FCF Ratio
--97.84-31.02-24.49-27.71-12.82
Debt / Equity Ratio
2.442.443.330.970.863.14
Debt / EBITDA Ratio
-1.37-1.37-0.70-0.83-0.54-0.40
Debt / FCF Ratio
-2.30-2.30-1.49-1.28-0.81-0.46
Net Debt / Equity Ratio
-1.22-1.22-2.17-1.05-0.97-2.35
Net Debt / EBITDA Ratio
0.680.680.450.890.610.30
Net Debt / FCF Ratio
1.141.140.961.370.910.34
Asset Turnover
1.011.010.670.590.240
Inventory Turnover
2.172.172.162.682.41-
Quick Ratio
1.441.441.993.462.473.75
Current Ratio
1.551.552.113.632.543.75
Return on Equity (ROE)
-252.11%-252.11%-231.63%-159.21%-298.97%-201.51%
Return on Assets (ROA)
-26.43%-26.43%-48.52%-50.62%-85.77%-91.05%
Return on Invested Capital (ROIC)
-327.19%-327.19%-539.58%-418.40%-1866.52%606.97%
Return on Capital Employed (ROCE)
-51.36%-51.36%-71.23%-67.76%-120.01%-109.67%
Earnings Yield
-2.25%-2.01%-7.08%-6.62%-5.96%-9.18%
FCF Yield
-1.15%-1.01%-3.12%-3.87%-3.49%-7.60%
Buyback Yield / Dilution
-1.30%-1.30%-1.64%-7.15%-7.44%-0.82%
Updated Feb 23, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q